||The current quality indicator sets for diabetes care lacks good indicators for measuring the quality of medication treatment. The aim of this project is to develop a set of valid indicators to be used for evaluating and improving chronic medication treatment in patients with type 2 diabetes. These novel prescribing quality indicators should (1) capture the quality of chronic treatment over time, (2) take into account differentiation for patient characteristics, (3) predict better patient outcomes, and (4) be measurable using routinely collected data from primary care.|
The project consists of three phases needed for development and implementation of valid quality indicators. In phase 1, the indicators will be defined and judged on reflecting evidence and guideline recommendations by an expert panel, including patient representatives. The operational and statistical validity will be tested using routinely collected healthcare data for >85.000 diabetes patients. In phase 2, the selected indicators will be tested for predictive validity on a composite outcome of diabetes-related complications and death in >20.000 patients. In subsets of around 1300 patients, the predictive validity on quality of life will be assessed as well. The prescribing quality indicators that show to be associated with either clinical or quality of life outcomes, are considered valid for educational and benchmarking purposes in actual practice. In phase 3, a plan will be made in cooperation with national authorities responsible for measuring and improving quality of care to set off the implementation and evaluation of using this final set of prescribing quality indicators in practice.